- Conditions
- Overactive Bladder, Bladder, Overactive, Urge Incontinence, Urgency Urinary, Urinary Frequency/Urgency
- Interventions
- Transvaginal botulinum toxin A (BTA) injection
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Stanford, California
Source: ClinicalTrials.gov public record
Updated Jul 18, 2022 · Synced May 22, 2026, 1:26 AM EDT